Skip to main content
  • Trial: NOAC Continuation OK Through Afib Ablation

    No difference seen in event rates or cognitive, quality of life outcomes

    Uninterrupted anticoagulation during atrial fibrillation (Afib) ablation appeared as safe with apixaban (Eliquis) as with warfarin (Coumadin) or other vitamin K antagonist for patients at stroke risk in the AXAFA-AFNET 5 trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details